Endocrine Abstracts

Background: Alemtuzumab is an anti-CD52 monoclonal antibody used in the treatment of relapsing and remitting Multiple Sclerosis (MS). It is a highly effective medication however common side effects of the treatment can include Autoimmune thyroid disease (Graves’ disease, Hashimoto’s thyroiditis), idiopathic thrombocytopenic purpura, anti-glomerular basement membrane disease, neutropenia, haemolytic anaemia, vitiligo being the most common presentation. This case highl...

As per NICE guideline, referral for parathyroidectomy need to be according the below, • symptoms of hypercalcaemia or • End-organ disease (renal stones, fragility fractures or osteoporosis) or • An albumin-adjusted serum calcium level of 2.85 mmol/litre or above.Methods: We conducted a retrospective analysis of investigations done as per recommendation of NICE guidelines for patients who underwent Parathyroidectomy under t...